Skip to content

Pharma and biotech

Pharma and biotech

Multi-omics characterization of mechanism of action, response biomarkers and translational consistency.

3
programs
3
therapeutic areas
4
questions along the pipeline

Programs

Our programs

Xplorer™ program

Biomarker Xplorer™

Find the markers that separate two groups, and confirm them before you build on them.

  • DNA, RNA and proteins read against one question
  • Bulk RNA-seq; single-cell and spatial through Transcriptomics 360
  • Confirmation by qPCR or dPCR on the full sample set
3
levels: DNA, RNA, proteins
4
questions
9
application areas

Xplorer™ program

Microbiome Xplorer™

How a treatment, a diet or a product reshapes a microbial community, and how the host responds.

  • 16S and shotgun metagenomics
  • Metatranscriptomics and metabolomics on site
  • Host markers on the same samples
4
layers measured
4
questions
7
application areas

360 offer

Transcriptomics 360

Bulk, single-cell and spatial transcriptomics run as one program, on one design and one sample set.

  • Bulk RNA-seq in Marseille
  • Single-cell transcriptomics
  • Spatial transcriptomics
3
modalities
1
design, one sample set
1
project lead

Along the pipeline

What we measure along the pipeline

Four questions, from the target to the translational follow-up, each read with the omics that answer it.

  1. Target

    Which molecular changes are primary effects rather than downstream consequences or stress responses?

    • Transcriptomics
    • Proteomics
    • Metabolomics, on site
  2. Response to treatment

    How does the response develop across dose and time, and where does it plateau or switch on?

    • Transcriptomics
    • Proteomics
    • Metabolomics, on site
  3. Biomarkers

    Which markers separate the two groups, and do they hold on data not used to derive them?

    • Genomics
    • Transcriptomics
    • Proteomics
    • Confirmation by qPCR or dPCR
  4. Translational follow-up

    Is a response seen in one model conserved in another, and are the signatures found again in patient-derived material?

    • Transcriptomics
    • Proteomics
    • Single-cell and spatial transcriptomics

Working with us

Three ways to work with us

Same team, same laboratories.

  1. 01

    On-demand service

    A platform order delivers primary data. Alignment, quantification, integration, biomarker discovery and modeling are run by our computational team: ask for it in the quote request and both are scoped together.

    See the laboratory platforms
  2. 02

    Outsourced R&D programs

    Your R&D, entrusted to GENXMAP and run by a PhD-level project lead.

    About outsourced R&D
  3. 03

    Collaborative & strategic partnership programs

    Co-developed with laboratories and industrial partners: shared milestones and costs, often multi-year.

    About partnership programs

R&D and partnerships

Questions we get asked

Scoping a study

What do you need to scope a study?

Four things: the compound or intervention, the model system, the endpoint, and the decision the result must support. With those we recommend the platforms and send a quote within 2 business days. A finished protocol is not required: our scientific scoping service exists for exactly that.

Direct link to this question
Which samples can we send for a pharma or biotech study?

Cell lines, treated cultures, animal tissue, plasma and extracted nucleic acid. Input and quality criteria are published per sample type. Plate-format submissions are supported for screening series, with the plate map carried through to the result tables. Packaging rules are in the sample submission guidelines.

Direct link to this question
Can you analyze screening or omics data produced elsewhere?

Yes. DNA-seq and RNA-seq, proteomics, metabolomics and screening data can be analyzed on their own terms. Data produced elsewhere often arrive without the metadata the analysis needs: we tell you what can be concluded before any work starts, rather than after.

Direct link to this question

Running and delivering

Can you apply the compound before the measurement?

Yes. Where a program needs the compound applied before the readout, The partner laboratory provides the model and runs the treatment, and the treated material comes to us for extraction, QC and the omics layers. The model is chosen for the question: primary cells, reconstructed tissue or an established line.

Direct link to this question
What does a pharma study report contain?

A report written to be reviewed, challenged and reproduced. Matrices, tables and versioned pipelines come with it, for internal review or independent reproduction. QC is reported per sample, with exclusions stated and justified, and the interpretation is written against the question the study started from.

Direct link to this question
How long does a pharma study take?

A study takes 4–6 weeks as standard or 2–4 weeks as priority, in working days from GO, which is given after the visual check of your samples on reception. The date is confirmed in the quote, and routine services take 3 business days once set-up is validated.

Direct link to this question

Confidentiality

Is our data confidential, and does an AI see it?

Yes, your data is confidential. A mutual NDA is available before any detail is shared, at no charge. Data is hosted in the EU, with backups in France, in a separate space per team.

Direct link to this question

A project in this field?

Tell us the compound, the model, the endpoint and the decision it must support